FeesSafety
Pluang+

Nautilus Biotechnology expands Voyager platform into oncology, boosting proteomics research potential.

Analyst Insights
29 Oct 2026, 06:16 WIB
Seeking Alpha
View Source
Bullish
Nautilus Biotechnology expands Voyager platform into oncology, boosting proteomics research potential.

Nautilus Biotechnology (NAUT) is extending its Voyager platform from tau protein analysis into oncology, broadening its applications in targeted proteoform research. The company has ongoing research collaborations and participates in SEEDS, indicating strong scientific interest in its technology. Management believes current funding will support the launch of Voyager instruments and initial assay kits as planned. This positions NAUT as a promising long-term investment for those interested in proteomics research tools.

Nautilus Biotechnology's recent developments are presented here with Pluang's Health-sector market data as of Oct 29, 2026 07:11 WIB. Among 150 priced US Health-sector stocks tradable on Pluang, 105 rose and 44 fell today. Notable movers include DNA (Ginkgo Bioworks Holdings Inc) at USD 13.23 with a 1-day change of +17.39% and a Pluang order activity split of 45% Sell / 55% Buy, TDOC (Teladoc Health Inc) at USD 7.50 with a 1-day change of +16.28%, and SLS (SELLAS Life Sciences Group Inc. Common Stock) at USD 10.37 with a 1-day change of -14.79%. The most notable figure is DNA's +17.39% increase.

More News

Global music market to grow at 8.07% CAGR, reaching $57.74B by 2032 driven by streaming and digital access.

Global music market to grow at 8.07% CAGR, reaching $57.74B by 2032 driven by streaming and digital access.

The global music market is projected to grow from $36.13 billion in 2026 to $57.74 billion by 2032, at a CAGR of 8.07%, fueled by paid streaming subscriptions, smartphone adoption, and digital music discovery. North America remains the largest market...

Market News
Bullish
1 hour ago
LUXEED hosts global media test drive showcasing advanced tech and luxury in new LLounge and Stormax models.

LUXEED hosts global media test drive showcasing advanced tech and luxury in new LLounge and Stormax models.

LUXEED held a global media test drive event at Chery's International Headquarters in Vu Hồ, featuring the luxury MPV LLounge and the high-performance Stormax SUV. Media representatives and influencers from UAE, Thailand, and Indonesia experienced a 1...

Market News
Bullish
3 hours ago
FDA grants orphan drug status to sovleplenib for rare autoimmune disease ITP treatment

FDA grants orphan drug status to sovleplenib for rare autoimmune disease ITP treatment

HUTCHMED announced that the US FDA has granted orphan drug designation to sovleplenib for treating primary immune thrombocytopenia (ITP), a rare autoimmune disorder causing low platelet counts and bleeding risks. This status provides benefits like 7 ...

Market News
Bullish
3 hours ago
China's coffee market to reach $8.04B by 2032, driven by cafe culture and specialty coffee growth.

China's coffee market to reach $8.04B by 2032, driven by cafe culture and specialty coffee growth.

China's coffee market is projected to grow from $5.8 billion in 2026 to $8.04 billion by 2032, at a CAGR of 5.54%. Growth is fueled by expanding chain cafes, specialty coffee methods like cold brew, and rising homegrown brands. However, rising coffee...

Market News
Neutral
3 hours ago
Union Bankshares Q3 net income rises to $3.8M but growth and dividend concerns keep hold rating

Union Bankshares Q3 net income rises to $3.8M but growth and dividend concerns keep hold rating

Union Bankshares reported a Q3 2026 net income of $3.8 million ($0.77 per share), showing sequential and year-over-year improvements. However, the bank's book value per share declined by 12.8%, and despite accelerated loan and deposit growth, risks r...

Company Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App